Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alternativeName |
gptkb:WAY-103
|
| gptkbp:CASNumber |
144167-97-5
|
| gptkbp:chemicalFormula |
C19H21N3O2
|
| gptkbp:developedBy |
gptkb:Wyeth-Ayerst
|
| gptkbp:drugClass |
antagonist at serotonin 5-HT1A receptors
|
| gptkbp:has_research_use |
neuropharmacology
|
| gptkbp:hasSMILES |
C1CN(CCN1C2=CC=CC=N2)CCNC(=O)C3=CC=CC=C3
|
| gptkbp:heldBy |
5-HT1A receptor antagonist
|
| https://www.w3.org/2000/01/rdf-schema#label |
AMD-103
|
| gptkbp:is_not_approved_for_medical_use |
true
|
| gptkbp:IUPACName |
N-[2-(4-pyridin-2-ylpiperazin-1-yl)ethyl]benzamide
|
| gptkbp:molecularWeight |
323.39 g/mol
|
| gptkbp:PubChem_CID |
132345
|
| gptkbp:bfsParent |
gptkb:GE_Genesis_locomotives
|
| gptkbp:bfsLayer |
7
|